Anzeige
Mehr »
Donnerstag, 09.04.2026 - Börsentäglich über 12.000 News
Research Capital bestätigt $3,00 Kursziel - FUTR zündet die nächste Stufe: Vom Fintech zur globalen Finanzplattform
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von GlobeNewswire (USA)

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
14:06Cloudbreak Pharma, Inc.: Cloudbreak Pharma Announces Launch of Cloudbreakpharma.com to Raise Awareness of its Pipeline of Novel First-in-Class Therapeutics to Treat Serious Underserved Ophthalmic Diseases
14:06Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner
14:06LOBO Technologies Ltd.: LOBO Launches Claw AI Agent Platform to Accelerate AI Adoption in Export-Oriented Manufacturing
14:06Seer, Inc.: Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples
14:06Nautilus Biotechnology Inc.: Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
14:06Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026
14:00Solar A/S: No. 8 2026 Major shareholder announcement
13:54Nexalin Technology, Inc.: Nexalin Announces Peer-Reviewed Study Showing the Company's DIFS Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents
13:42Notice to Convene the Extraordinary General Meeting in RIAS A/S on 6 May 2026
13:42Entree Resources Ltd: Entrée Resources Provides JV Licenses Update and Drill and Regional Exploration Results
13:36AGF Management Ltd.: AGF Launches Capitol Signals, a Subscription-Based Newsletter
13:36Kura Oncology, Inc.: Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026
13:36InflaRx N.V.: InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor
13:36PMGC Holdings Inc.: AGA Precision Systems Signs Second Long-Term Supply Agreement to Manufacture Aerospace and Defense Components for a Tier 1 Firm
13:36Bombardier Inc.: Bombardier to Report First Quarter 2026 Financial Results and Host Annual General Meeting of Shareholders on April 30, 2026
13:36Bitcoin Bancorp, Inc.: Bitcoin Bancorp Launches California Deployment of Licensed Bitcoin ATM Network With First Installations
13:30Exodus Launches Exodus Pay to Let Users Spend, Send, and Earn Rewards from One App
13:06New Era Energy & Digital, Inc.: New Era Energy & Digital Announces Pricing of $100 Million Public Offering of Common Stock
13:06Indivior Pharmaceuticals Inc.: Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th
13:06GXO Logistics: GXO Appoints Commercial Leader to Accelerate Scalable Growth and Strengthen Long-Term Partnerships
13:06Foghorn Therapeutics, Inc.: Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting
13:06Scotts Miracle-Gro Company (The): ScottsMiracle-Gro Completes Divestiture of Hawthorne Subsidiary
13:06NetraMark Holdings Inc.: Netramark-Authored, Peer-Reviewed Article Suggests Psychedelics Might Not Only Affect Brain Chemistry, They May Also Involve Quantum-Level Processes Inside the Brain
13:06Seres Therapeutics, Inc.: Seres Therapeutics to Present at CARB-X Investor Day
12:36WisdomTree Multi Asset Issuer PLC: WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY (a public company incorporated with limited liability in Ireland) WISDOMTREE WTI CRUDE OIL 3X DAILY SHORT SECURITIES ISIN: XS2819844387